Han Na Kang
- Molecular Biology
- Oncology
- Pulmonary and Respiratory Medicine
- Cancer Research
- Pathology and Forensic Medicine
- Co-authors
- Sang Cheul OhYoung A. YooByoung Chul ChoMyoung Hee KangJun Suk KimJung Lim KimHyun Joo LeeHye Ryun Kim
- Topics
- Lung Cancer Treatments and Mutations (7 papers)Lung Cancer Research Studies (3 papers)HER2/EGFR in Cancer Research (3 papers)
- Partner nations
- South KoreaUnited StatesUnited Kingdom
In The Last Decade
Han Na Kang
18 papers receiving 379 citations
Peers
Comparison fields: 5 of 56
- Molecular Biology 228
- Oncology 162
- Pulmonary and Respiratory Medicine 133
- Cancer Research 77
- Pathology and Forensic Medicine 36
Countries citing papers authored by Han Na Kang
This map shows the geographic impact of Han Na Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Na Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Na Kang more than expected).
Fields of papers citing papers by Han Na Kang
This network shows the impact of papers produced by Han Na Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Na Kang. The network helps show where Han Na Kang may publish in the future.
Co-authorship network of co-authors of Han Na Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Han Na Kang. A scholar is included among the top collaborators of Han Na Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Na Kang. Han Na Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 8 | |
| 5 | 28 | |
| 6 | 3 | |
| 7 | 83 | |
| 8 | 46 | |
| 9 | 24 | |
| 10 | 1 | |
| 11 | 23 | |
| 12 | 1 | |
| 13 | 6 | |
| 14 | 20 | |
| 15 | 16 | |
| 16 | 5 | |
| 17 | 21 | |
| 18 | 95 |
About Han Na Kang
Han Na Kang is a scholar working on Oncology, Toxicology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 385 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (162 citations), Cancer Research (77 citations) and Pulmonary and Respiratory Medicine (133 citations). Han Na Kang has collaborated with scholars based in South Korea, United States and United Kingdom. Frequent co-authors include Sang Cheul Oh, Young A. Yoo, Byoung Chul Cho, Myoung Hee Kang, Jun Suk Kim, Jung Lim Kim, Hyun Joo Lee, Hye Ryun Kim, Mi Ran Yun and Kyoung‐Ho Pyo. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.